GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Retail - Cyclical » Innovative Pharmaceutical Biotech Ltd (HKSE:00399) » Definitions » Accounts Receivable

Innovative Pharmaceutical Biotech (HKSE:00399) Accounts Receivable : HK$3.37 Mil (As of Sep. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Innovative Pharmaceutical Biotech Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Innovative Pharmaceutical Biotech's accounts receivables for the quarter that ended in Sep. 2024 was HK$3.37 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Innovative Pharmaceutical Biotech's Days Sales Outstanding for the quarter that ended in Sep. 2024 was 203.17.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Innovative Pharmaceutical Biotech's Net-Net Working Capital per share for the quarter that ended in Sep. 2024 was HK$-1.01.


Innovative Pharmaceutical Biotech Accounts Receivable Historical Data

The historical data trend for Innovative Pharmaceutical Biotech's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innovative Pharmaceutical Biotech Accounts Receivable Chart

Innovative Pharmaceutical Biotech Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Accounts Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.61 15.32 9.26 6.17 4.91

Innovative Pharmaceutical Biotech Semi-Annual Data
Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.25 6.17 5.59 4.91 3.37

Innovative Pharmaceutical Biotech Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


Innovative Pharmaceutical Biotech Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Innovative Pharmaceutical Biotech's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=3.372/3.029*91
=203.17

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Innovative Pharmaceutical Biotech's accounts receivable are only considered to be worth 75% of book value:

Innovative Pharmaceutical Biotech's Net-Net Working Capital Per Share for the quarter that ended in Sep. 2024 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(0.428+0.75 * 3.372+0.5 * 0-907.618
-0-930.168)/1822.203
=-1.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Innovative Pharmaceutical Biotech Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Innovative Pharmaceutical Biotech's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Innovative Pharmaceutical Biotech Business Description

Traded in Other Exchanges
N/A
Address
145 Hennessy Road, Unit No. 2002, 20th Floor, On Hong Commercial Building, Wan Chai, Hong Kong, HKG
Innovative Pharmaceutical Biotech Ltd is a Hong Kong-based investment holding company principally engaged in pharmaceuticals and biotechnology businesses. The company has two operating segments; Trading of beauty products in Hong Kong and Research, development, and commercialisation of the oral insulin product. The company generates almost all of its revenue from Hong Kong.
Executives
Chau Yiu Ting 2101 Beneficial owner
Mao Yumin 2101 Beneficial owner
Extrawell Pharmaceutical Holdings Limited
Mao Yumin 2101 Beneficial owner
Chau Yiu Ting 2101 Beneficial owner

Innovative Pharmaceutical Biotech Headlines

No Headlines